Tubeless anesthesia techniques are increasingly adopted for carefully selected minimally invasive procedures, offering distinct advantages over traditional airway management methods. This review synthesizes the latest evidence and clinical guidelines, highlighting the indications, mechanisms, and outcomes associated with tubeless anesthesia in contemporary practice. Emphasis is placed on patient selection, safety considerations, and the implications for perioperative management, providing a comprehensive overview for anesthesiologists and surgical teams aiming to optimize care in minimally invasive interventions.
Minimally invasive procedures have revolutionized modern surgery by reducing patient morbidity, shortening hospital stays, and enhancing recovery. Anesthesia techniques have evolved in parallel, with tubeless anesthesia characterized by the avoidance of endotracheal intubation emerging as a viable option for selected interventions. This approach leverages advanced airway management strategies, adjuncts, and pharmacological innovations to ensure patient safety and procedural efficacy. Understanding the latest evidence and best practices surrounding tubeless anesthesia is essential for clinicians seeking to maximize procedural success and minimize perioperative complications.
With the global rise in minimally invasive surgeries, such as video-assisted thoracoscopic surgery (VATS), percutaneous nephrolithotomy, and select laparoscopic interventions, the demand for versatile anesthetic approaches has grown. Traditionally, these procedures utilized general anesthesia with endotracheal intubation to secure the airway and facilitate controlled ventilation. However, studies report that tubeless techniques are now being employed in 5–20% of indicated cases, with rates highest in specialized centers. This shift is driven by improvements in patient outcomes and a growing body of literature supporting the safety of tubeless approaches in suitable candidates.
Tubeless anesthesia leverages the patient’s ability to maintain spontaneous respiration without the need for invasive airway devices. The pathophysiological rationale centers on preserving normal mucociliary function, minimizing airway trauma, and reducing the risk of ventilator-induced lung injury. Oxygenation and ventilation are maintained through non-invasive methods such as supraglottic airway devices, high-flow nasal oxygen, or regional anesthesia. The absence of an endotracheal tube reduces the incidence of airway-related adverse events, such as laryngeal edema and postoperative hoarseness, while supporting a more physiological respiratory pattern throughout the procedure.
Patient selection is critical for the safe application of tubeless anesthesia. Risk factors that may contraindicate its use include high aspiration risk, anticipated difficult airway, obesity (BMI >35 kg/m2), severe obstructive sleep apnea, and significant pulmonary comorbidities. Surgical factors, such as prolonged operative time, need for one-lung ventilation, or procedures with a high risk of intraoperative airway compromise, also favor traditional airway management techniques. Comprehensive preoperative assessment and multidisciplinary planning are essential for identifying patients who are optimal candidates for tubeless techniques.
The clinical features of patients selected for tubeless anesthesia typically include good airway anatomy, preserved respiratory function, and low risk of aspiration. Intraoperatively, these patients maintain spontaneous ventilation, exhibit stable hemodynamics, and often experience less coughing and bucking during emergence. Postoperative benefits observed in the literature include reduced sore throat, faster recovery of protective airway reflexes, and lower incidence of nausea and vomiting. These features contribute to enhanced patient satisfaction and improved perioperative outcomes in appropriate cases.
Diagnosis in the context of tubeless anesthesia refers to the careful preoperative evaluation process required to determine eligibility. This involves thorough airway assessment (Mallampati score, thyromental distance), evaluation of pulmonary and cardiac status, and consideration of the planned procedure’s requirements. Additional investigations, such as pulmonary function tests or sleep studies, may be warranted in select cases. Risk stratification tools and multidisciplinary input are vital to ensure patient safety and procedural success in the absence of an endotracheal tube.
Tubeless anesthesia management encompasses several strategies tailored to patient and procedural needs. Techniques may include deep sedation with spontaneous respiration, use of laryngeal mask airways, high-flow nasal oxygen therapy, or regional anesthesia alone or in combination with light sedation. Intraoperative monitoring is intensified, with capnography, pulse oximetry, and vigilant airway observation to promptly detect hypoventilation or desaturation. Rescue plans, including readiness for rapid airway instrumentation, are mandatory. Postoperative care focuses on early mobilization, airway monitoring, and prompt identification of any respiratory compromise.
Recent advances in tubeless anesthesia include the adoption of high-flow nasal oxygen (HFNO) for extended apneic oxygenation, novel supraglottic airway devices with enhanced sealing and safety features, and closed-loop sedation systems that optimize drug delivery for spontaneous ventilation. Clinical trials have demonstrated the feasibility of tubeless techniques in complex procedures, such as non-intubated VATS and awake craniotomies, expanding the scope of eligible cases. Enhanced recovery protocols increasingly incorporate tubeless anesthesia as a means of reducing perioperative morbidity and facilitating ambulatory surgery pathways.
Professional societies, including the European Society of Anaesthesiology and Intensive Care (ESAIC) and the American Society of Anesthesiologists (ASA), advocate for individualized, risk-based approaches to airway management. Current guidelines endorse tubeless anesthesia for selected minimally invasive procedures in patients with favorable risk profiles and emphasize the need for robust backup strategies. Emphasis is placed on multidisciplinary planning, simulation-based team training, and continuous quality improvement to ensure the highest standards of patient safety during tubeless interventions.
Tubeless anesthesia techniques represent a significant advancement in the management of selected minimally invasive procedures. When applied to appropriately chosen patients, these methods provide clear clinical benefits, including reduced airway trauma, expedited recovery, and improved patient satisfaction. Careful patient selection, adherence to evidence-based protocols, and ongoing research into emerging technologies will continue to shape the future of tubeless anesthesia, ensuring its safe integration into modern perioperative practice.
1.
Tumor characteristics found to differ for melanomas in children, teens and young adults
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
5.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
1.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
2.
Screening for Early Therapy-Related Cancer Susceptibility
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Importance of Cancer Screening and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation